Home
Market Capitalization of Genomic Valley Biotech Ltd

Genomic Valley Biotech Ltd
NSE: GENOMICVALLEY
Market Cap
Key Highlights
- The Market Cap of Genomic Valley Biotech Ltd is ₹ 18.62 crore as of 21 Feb 25 .
- The Latest Trading Price of Genomic Valley Biotech Ltd is ₹ 60.97 as of 21 Feb 15:30 .

Genomic Valley Biotech Ltd
NSE: GENOMICVALLEY
Share Price
Market Price of Genomic Valley Biotech Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 60.97 |
20 Feb 2025 | 59.78 |
19 Feb 2025 | 58.61 |
18 Feb 2025 | 55.82 |
17 Feb 2025 | 53.17 |
14 Feb 2025 | 50.64 |
13 Feb 2025 | 48.23 |
12 Feb 2025 | 45.94 |
11 Feb 2025 | 43.76 |
10 Feb 2025 | 43.5 |
BlinkX Score for Genomic Valley Biotech Ltd
Asset Value vs Market Value of Genomic Valley Biotech Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Genomic Valley Biotech Ltd
Historical P/E Ratio of Genomic Valley Biotech Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Genomic Valley Biotech Ltd
Historical Revenue of Genomic Valley Biotech Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Genomic Valley Biotech Ltd
Historical EBITDA of Genomic Valley Biotech Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Genomic Valley Biotech Ltd
Historical Net Profit of Genomic Valley Biotech Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Genomic Valley Biotech Ltd
Dividend Payout Over Time
About Genomic Valley Biotech Ltd
- Incorporated in May 1994, Genomic Valley Biotech Limited is formed with the objective of conducting research in the field of Biotechnology (Plant & Animal) and also to undertake commercial production of Plant Tissue Cultured Plants of different species to feed the genetically improved plant market nationally as well as internationally.
- The Company is extensively involved in commercial greenhouse / poly house cultivation of crops.
- Presently, it is engaged in high-tech cultivation through environmental controlled Poly Houses,NFT & DFT etc,manufacturing of Tissue Cultured Improved variety of plants and organic farming using Bio-Fertilizer.
- Also it is involved in commercial Horticulture activities with Aloe vera, Tomato, Bitter Gourd, Bottle Gourd, Brinjal, Broccoli, Cabbage, Capsicum, Carrot, Cauliflower, Cucumber, Green Chillies, Onion, Radish, Ridge/Sponge Gourd, Leafy Vegetables, Pumpkin, Banana, Guava, Papaya, and Strawberry.
Genomic Valley Biotech Ltd News Hub
Genomic Valley Biotech standalone net profit rises 650.00% in the September 2024 quarter
Net profit of Genomic Valley Biotech rose 650.00% to Rs 0.15 crore in the quarter ended September 20
Read more
08 Oct 24
Genomic Valley Biotech to discuss results
Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 7 October 202
Read more
03 Oct 24
Genomic Valley Biotech to convene board meeting
Genomic Valley Biotech will hold a meeting of the Board of Directors of the Company on 14 February 2
Read more
11 Feb 25
Genomic Valley Biotech schedules AGM
Genomic Valley Biotech announced that the Annual General Meeting(AGM) of the company will be held on
Read more
07 Dec 24